Resistencia a los antimicrobianos

Antimicrobial Resistance Multi-Partner Trust Fund (AMR MPTF)

Status: Ongoing

Donor: Multi-donor: Governments of Germany (through the German Agency for International Cooperation – GIZ), the Netherlands, Sweden (including through the Swedish International Development Cooperation Agency – Sida) and the United Kingdom of Great Britain and Northern Ireland (using UK aid funding through the Fleming Fund)and

Intervention areas:

 

  • Ten countries (Cambodia, Ethiopia, Ghana, Indonesia, Kenya, Morocco, Peru, Tajikistan, Senegal and Zimbabwe). More country programmes are under the development.
  • One global programme with four technical components. They are Integrated surveillance system for AMR/AMU; One Health legal assessment tool for AMR; Environmental dimension of AMR; Monitoring and Evaluation framework for the National Action Plan on AMR.  

Period:  AMR MPTF started in 2019 and currently continues to end 2030.  One project cycle lasts 3 years maximum.

Objectives:  The AMR MPTF is a significant instrument aligned with the Quadripartite Strategic Framework for collaboration on AMR which has as its goal, preserving antimicrobial efficacy and ensuring sustainable and equitable access to antimicrobials for responsible and prudent use in human, animal and plant health contributing to achieving the Sustainable Development Goals.  

The objectives of the fund include:

  • To reduce levels and slower development of AMR.
  • To maintain the ability to treat infectious diseases with effective and safe antimicrobials.
  • To reduce the impact of AMR on human and animal health, the environment, and economic development for populations worldwide.

Outcomes and outputs:

Outcome 1. Risks and benefits of AMR reflected in national budgets and in development/multi-lateral partners sector-wide investment

Outcome 2. Increased comprehensiveness and quality of the policy dialogue and practice

Outcome 3. Evidence base/representative data on AMR/AMU improved for policy-makers and sectors implementing AMU practices

Outcome 4. Use of antimicrobials optimized in critical sectors

Outcome 5. Improved understanding of AMR risks and response options by targeted groups

Outcome 6.  Multi-sectoral coordination strengthened at national level

Outcome 7. Momentum on Global AMR Agenda sustained

 

Output 1. Improved countries capacities for designing and implementing AMR related policy frameworks, investment plans and programmes

 Output 2. Improved countries capacities for mainstreaming and for costing AMR as well as changes in practices to minimize AMR

Output 3.Engagement plans with critical stakeholder groups implemented

Output 4. Systems for generating, analysing and interpreting data on resistance and consumption/use patterns developed or strengthened

Output 5. Systems for biosecurity and IPC strengthened in targeted countries

Output 6: Systems for optimized use strengthened in critical sectors

Output 7. Improved countries capacities to design targeted awareness/Behaviour Change raising initiatives

Output 8. Evidence-based and cost-effective priority actions developed for different contexts

Output 9. Strategic global-level governance advocacy initiatives on AMR implemented

Share this page